NASDAQ:CLLS

Cellectis S.a Stock Forecast

etoro logo Buy CLLS
*Your capital is at risk
$3.06
-0.0900 (-2.86%)
At Close: Jun 05, 2026
AI Analysis AI Analysis of CLLS AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add CLLS to Watchlist?
Some Reasons Why To Add CLLS:
  • +117.0% price growth over the last year
  • High gross margin of 78.9%
  • Bullish trend confirmed on both short and long timeframes
PDF

Red day on Friday for Cellectis S.A.
(Updated on Jun 05, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since May 26, 2026 Loss -16.62%

The Cellectis S.A. stock price fell by -2.86% on the last day (Friday, 5th Jun 2026) from $3.15 to $3.06. During the last trading day the stock fluctuated 5.28% from a day low at $3.03 to a day high of $3.19. The price has fallen in 7 of the last 10 days and is down by -13.07% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -54 thousand shares and in total, 47 thousand shares were bought and sold for approximately $143.42 thousand.

Given the current short-term trend, the stock is expected to rise 3.96% during the next 3 months and, with a 90% probability hold a price between $3.18 and $4.69 at the end of this 3-month period.

CLLS Signals & Forecast

There are few to no technical positive signals at the moment. The Cellectis S.A. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $3.33 and $3.76. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, April 17, 2026, and so far it has fallen -30.77%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Cellectis S.A. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.160 between high and low, or 5.28%. For the last week the stock has had daily average volatility of 5.08%.

Cellectis S.A. is oversold on RSI14 (19). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CLLS) For The Upcoming Trading Day Of Monday 8th

For the upcoming trading day on Monday, 8th we expect Cellectis S.A. to open at $3.09, and during the day (based on 14 day Average True Range), to move between $2.96 and $3.16, which gives a possible trading interval of +/-$0.201 (+/-6.81%) up or down from last closing price. If Cellectis S.A. takes out the full calculated possible swing range there will be an estimated 6.81% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $3.33, some $0.270 (8.82%) from the current price of $3.06, our system finds the risk reward not very attractive.

Is Cellectis S.A. stock A Buy?

The Cellectis S.A. stock holds several negative signals and despite the positive trend, we believe Cellectis S.A. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -3.962 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 8, 2026 - $3.09 ( 1.09%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

CLLS Performance

Trading levels for CLLS

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 3.25 6.32%
R2 3.19 4.32%
R1 3.15 3.09%
Price 3.06
S1 3.03 -0.91%
S2 2.99 -2.14%
S3 2.93 -4.14%

Accumulated Volume Support & Resistance Levels

Level Price
R3 3.63 18.63%
R2 3.60 17.65%
R1 3.33 8.82%
Price 3.06
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for Cellectis S.A. Stock and on which exchange is it traded?
The symbol for Cellectis S.A. is CLLS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Cellectis S.A. Stock?
The Cellectis S.A. stock holds several negative signals and despite the positive trend, we believe Cellectis S.A. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Cellectis S.A. Stock?
Cellectis S.A. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Cellectis S.A. Stock.

What's the current price of Cellectis S.A. Stock?
As of the end of day on the Jun 05, 2026, the price of an Cellectis S.A. (CLLS) share was $3.06.

What is the 52-week high and low for Cellectis S.A. Stock?
The 52-week high for Cellectis S.A. Stock is $5.48 and the 52-week low is $1.33.

What is the market capitalization of Cellectis S.A. Stock?
As of the Jun 05, 2026, the market capitalization of Cellectis S.A. is 307.276M.

When is the next earnings date for Cellectis S.A.?
The upcoming earnings date for Cellectis S.A. is Aug 11, 2026.
Click to get the best stock tips daily for free!
ABOUT CELLECTIS S.A.
Cellectis S.A
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatment of CD19-expressing hematologic malignancies, such as acute lymphoblastic leukemia; ALLO-501 and ALL...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
4.43% Jun 01
N
NVRI
$19.53
0.87% May 20
RUN
$12.83
15.51% May 06
GLBE
$31.61
4.05% May 05
SAP
$172.39
8.56% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE